Press release
United States Generalized Pustular Psoriasis Market Size, Share, Growth Trends, and Forecast Analysis (2024-2031) - Biologics, Targeted Therapies, and Emerging Treatment Innovations | Bristol Myers Squibb, UCB, Inc, Pfizer Inc.
Generalized Pustular Psoriasis Market
The generalized pustular psoriasis (GPP) market focuses on therapies for this rare, severe form of psoriasis characterized by widespread pustules and systemic symptoms. Treatment options include systemic drugs, biologics, and emerging targeted therapies. Rising prevalence of autoimmune skin diseases and increased awareness drive market growth. Recent approvals of biologics targeting IL-36 pathways are transforming the treatment landscape. Pharmaceutical companies are actively conducting clinical trials for more effective therapies. Patient advocacy and growing healthcare access also support market expansion.
π Download Sample Report to Identify Emerging Deals & Opportunities in the Generalized Pustular Psoriasis Market Landscape:- https://datamintelligence.com/download-sample/generalized-pustular-psoriasis-market?rk
β Generalized Pustular Psoriasis Market Recent Developments 2025:
United States: Recent Industry Developments
β In August 2025, AbbVie launched next-generation biologics targeting IL-36 pathways for generalized pustular psoriasis (GPP) treatment.
β In July 2025, Novartis expanded its psoriasis therapy portfolio with novel IL-targeted drugs for acute GPP flares.
β In June 2025, Janssen Pharmaceuticals partnered with dermatology centers to deploy advanced GPP management protocols, improving patient outcomes.
Europe: Recent Industry Developments
β In July 2025, Almirall launched targeted biologics for GPP in EU markets, focusing on rapid symptom control.
β In June 2025, Novartis Europe expanded its psoriasis treatment programs, integrating patient support for flare management.
β In May 2025, AbbVie Europe partnered with dermatology clinics to implement next-generation GPP therapies, improving quality of life for patients.
Japan: Recent Industry Developments
β In July 2025, Maruho Co., Ltd. launched biologic therapies for GPP in Japan, focusing on IL-36 inhibition.
β In June 2025, AbbVie Japan expanded its psoriasis portfolio, supporting rapid and sustained symptom relief.
β In May 2025, Novartis Japan partnered with dermatology centers to implement advanced treatment protocols, enhancing patient outcomes.
β Generalized Pustular Psoriasis Market Trends:
Generalized pustular psoriasis (GPP) is a rare, severe autoimmune skin disorder characterized by widespread pustules and systemic inflammation. Treatments include biologics, systemic immunosuppressants, and supportive therapies to manage flares and prevent complications. The market is growing due to increasing awareness, clinical research on biologic therapies, and rising prevalence of autoimmune skin disorders.
The adoption of targeted biologic therapies and novel systemic treatments is driving market expansion. North America and Europe lead due to high diagnosis rates, advanced healthcare infrastructure, and reimbursement support. Asia-Pacific is emerging with growing dermatology care access, increasing patient awareness, and rising R&D in novel therapeutics. Challenges include high treatment costs and limited patient population.
β Generalized Pustular Psoriasis Market Competitve Landscape:
Bristol Myers Squibb, UCB, Inc, Pfizer Inc., AbbVie Inc., Novartis AG, Astellas Pharma Inc., Eli Lilly and Company, Amgen Inc., Johnson & Johnson, AstraZeneca.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
π Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/generalized-pustular-psoriasis-market
β Segment Covered in the Generalized Pustular Psoriasis Market:
By Treatment: Topical Agents (Calcipotriol, TacrolimusNon-biologic agents (Cyclosporin, Methotrexate, Oral Retinoids, Others), Biologic agents (Interleukin antagonists, Guselkumab, Brodalumab, Others, TNFΞ± antagonists (Adalimumab, Certolizumab), Antibiotics.
By Route of Administration: Oral, Topical, Subcutaneous, Other.
By End User: Hospitals, Dermatology Clinics, Specialty Centers, Others
β This Report Includes:
β Comprehensive go-to-market strategies with actionable insights.
β Unbiased evaluation of overall market performance.
β Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
β Tailored regional and country-level reports with detailed localized analysis available on request.
β Identification of niche segments and high-growth regions presenting strong opportunities.
β Accurate regional forecasts using both top-down and bottom-up approaches.
π Get Corporate Access to Live Generalized Pustular Psoriasis Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=generalized-pustular-psoriasis-market
β Regional Analysis for Generalized Pustular Psoriasis Market:
β₯ North America (U.S., Canada, Mexico)
β₯ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
β₯ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
β₯ South America (Colombia, Brazil, Argentina, Rest of South America)
β₯ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
β Frequently asked questions:
β What is the global sales, production, consumption, import, and export value of the Generalized Pustular Psoriasis Market?
β Who are the key global manufacturers, and what is their operational performance?
β What are the major opportunities and threats in the global Generalized Pustular Psoriasis Market?
β Which product types or end-users show the most growth potential and market share?
β What challenges and constraints are impacting the Generalized Pustular Psoriasis Market?
β What sales, marketing, and distribution channels are used globally?
π Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
β Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
β Competitive Landscape
β Sustainability Impact Analysis
β KOL / Stakeholder Insights
β Unmet Needs & Positioning, Pricing & Market Access Snapshots
β Market Volatility & Emerging Risks Analysis
β Quarterly Industry Report Updated
β Live Market & Pricing Trends
β Import-Export Data Monitoring
β Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Generalized Pustular Psoriasis Market Size, Share, Growth Trends, and Forecast Analysis (2024-2031) - Biologics, Targeted Therapies, and Emerging Treatment Innovations | Bristol Myers Squibb, UCB, Inc, Pfizer Inc. here
News-ID: 4205423 • Views: β¦
More Releases from DataM Intelligence 4market Research LLP
Next-Generation Molecular Biosensors Market: AI-Integrated, Wearable, and Point- β¦
The Molecular Biosensors Market is valued at a significant CAGR during the forecast period (2024-2031).
The molecular biosensors market includes devices that detect biological molecules using biochemical reactions to provide rapid, sensitive analysis. They are widely applied in medical diagnostics, environmental monitoring, food safety, and biopharma research. Market demand is fueled by rising incidences of infectious and chronic diseases, driving point-of-care diagnostics. Integration with nanotechnology and microfluidics is enhancing sensitivity andβ¦
United States Medical Videoscope Market Insights: Minimally Invasive Surgery and β¦
The Medical Videoscope Market is valued at a significant CAGR during the forecast period (2024-2031).
The medical videoscope market covers advanced endoscopic imaging devices that provide high-resolution video visualization inside the body during diagnostic and surgical procedures. They are widely used in gastroenterology, urology, pulmonology, and ENT specialties. Rising demand stems from the growing preference for minimally invasive surgeries. Market growth is fueled by technological advancements such as 4K imaging, fluorescence,β¦
United States Predictive Genetic Testing & Consumer Wellness Genomics Market: Tr β¦
Predictive Genetic Testing and Consumer Wellness Genomics Market is valued at a significant CAGR of 14.3% during the forecast period (2024-2031). As per DataM Intelligence Database.
This market revolves around genetic tests that assess disease risks, carrier status, ancestry, and wellness-related traits for individuals. Predictive genetic testing helps identify potential health conditions early, supporting preventive healthcare. Consumer wellness genomics is gaining popularity through direct-to-consumer kits for fitness, nutrition, and lifestyle optimization.β¦
United States Plasma Sterilization Equipment Market: Technological Innovations a β¦
Plasma Sterilizer Market is estimated to grow at a CAGR of 6.5% during the forecast period 2024-2031
The plasma sterilizer market involves low-temperature sterilization devices that use hydrogen peroxide plasma to eliminate pathogens on medical instruments and equipment. They are increasingly adopted as safer alternatives to ethylene oxide or steam sterilization, especially for heat- and moisture-sensitive devices. Market growth is driven by rising hospital-acquired infection (HAI) concerns and stricter sterilization standards.β¦
More Releases for Generalized
Key Trends Influencing the Growth of the Generalized Anxiety Disorder Market in β¦
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Generalized Anxiety Disorder Market Through 2025?
In recent years, there has been a consistent expansion in the market size for generalized anxiety disorder. The market, which is predicted to grow from $7.76 billion in 2024 to $8.01 billion in 2025, will experienceβ¦
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder β¦
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected toβ¦
Key Generalized Anxiety Disorder Market Trend for 2025-2034: Innovative Drug Dev β¦
"What Is the Future Outlook for the Generalized Anxiety Disorder Market's Size and Growth Rate?
The generalized anxiety disorder market will grow from $7.76 billion in 2024 to $8.01 billion in 2025, at a CAGR of 3.2%. Growth is driven by increased mental health awareness, pharmaceutical advances, the popularity of cognitive-behavioral therapy (CBT), and the stressful lifestyle changes of modern society.
The generalized anxiety disorder market is expected to reach $9.32 billionβ¦
Global Generalized Anxiety Disorder Treatment Market Imapct of AI and Automation
Generalized Anxiety Disorder Treatment Market Impact of AI and Automation
The Generalized Anxiety Disorder (GAD) treatment market has been experiencing significant growth due to the increasing prevalence of anxiety disorders globally, rising awareness about mental health, and the development of advanced therapeutic options. In 2022, the market size was valued at approximately USD 7.5 billion and is expected to grow at a compound annual growth rate (CAGR) of around 6.5% fromβ¦
Generalized Anxiety Disorder Market Report and Forecast 2024-2032
Generalized Anxiety Disorder Market Outlook
The generalized anxiety disorder market size in the 7 major markets was valued at USD 1717.5 million in 2023, driven by the increasing advancements in psychotherapeutic as well as pharmacological treatment options for patients. The market is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, with the values likely to rise from USD 1809.8 million in 2024 to USD 2751.1β¦
Generalized Anxiety Disorder Pipeline Insight Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Generalized Anxiety Disorder Pipeline constitutes 10+ key companies continuously working towards developing 12+ Generalized Anxiety Disorder Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Generalized Anxiety Disorder Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Generalizedβ¦
